Some important/interesting microbiome related news for the week ending 6-24-18:

Axial Biotherapeutics and the Parkinson’s Institute Team up to study GI metabolites that may contribute to partnership. The two have formed a joint preclinical research collaboration, studying Axial’s microbiome-inspired interventions in the PICC’s unique cellular and animal models for PD and its effects over the GI system. Read article here.

Kallyope Inc. and Novo Nordisk A/S have entered into a research collaboration and option agreement to discover novel peptide therapeutics to treat obesity and diabetes. Read article here.

CosmosID receives highest score in in the strain-level microbial profiling category of the Mosaic Community Challenge and for strain-level microbial identification in the precisionFDA Pathogen Detection Challenge.  

To read the full article, please subscribe to our microbiome database, and you'll receive the rest of the report via email, as well as access to future reports.